298 related articles for article (PubMed ID: 36168240)
41. Comparison of microneedles and adhesive-tape stripping in skin preparation for epicutaneous allergen delivery.
Spina L; Weisskopf M; von Moos S; Graf N; Kündig TM; Senti G
Int Arch Allergy Immunol; 2015; 167(2):103-9. PubMed ID: 26279062
[TBL] [Abstract][Full Text] [Related]
42. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
43. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
[TBL] [Abstract][Full Text] [Related]
44. Transdermal Drug Delivery: A Step towards Treatment of Cancer.
Kriplani P; Guarve K
Recent Pat Anticancer Drug Discov; 2022; 17(3):253-267. PubMed ID: 34856914
[TBL] [Abstract][Full Text] [Related]
45. Progress and perspective of microneedle system for anti-cancer drug delivery.
Li D; Hu D; Xu H; Patra HK; Liu X; Zhou Z; Tang J; Slater N; Shen Y
Biomaterials; 2021 Jan; 264():120410. PubMed ID: 32979655
[TBL] [Abstract][Full Text] [Related]
46. Microneedle technologies for (trans)dermal drug and vaccine delivery.
van der Maaden K; Jiskoot W; Bouwstra J
J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
[TBL] [Abstract][Full Text] [Related]
47. Hollow microneedles: A perspective in biomedical applications.
Cárcamo-Martínez Á; Mallon B; Domínguez-Robles J; Vora LK; Anjani QK; Donnelly RF
Int J Pharm; 2021 Apr; 599():120455. PubMed ID: 33676993
[TBL] [Abstract][Full Text] [Related]
48. Microneedles-Based Transdermal Drug Delivery Systems: A Review.
Hao Y; Li W; Zhou X; Yang F; Qian Z
J Biomed Nanotechnol; 2017 Dec; 13(12):1581-1597. PubMed ID: 29490749
[TBL] [Abstract][Full Text] [Related]
49. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
Han T; Das DB
J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
[TBL] [Abstract][Full Text] [Related]
50. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
Shakya AK; Lee CH; Uddin MJ; Gill HS
Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
[TBL] [Abstract][Full Text] [Related]
51. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
52. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.
Lee IC; Lin WM; Shu JC; Tsai SW; Chen CH; Tsai MT
J Biomed Mater Res A; 2017 Jan; 105(1):84-93. PubMed ID: 27539509
[TBL] [Abstract][Full Text] [Related]
53. Microneedle applications in improving skin appearance.
McCrudden MT; McAlister E; Courtenay AJ; González-Vázquez P; Singh TR; Donnelly RF
Exp Dermatol; 2015 Aug; 24(8):561-6. PubMed ID: 25865925
[TBL] [Abstract][Full Text] [Related]
54. [Development of a novel transdermal delivery system of peptide and protein drugs using microneedle arrays].
Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
Yakugaku Zasshi; 2014; 134(1):63-7. PubMed ID: 24389619
[TBL] [Abstract][Full Text] [Related]
55. Microneedle delivery: clinical studies and emerging medical applications.
Pettis RJ; Harvey AJ
Ther Deliv; 2012 Mar; 3(3):357-71. PubMed ID: 22833995
[TBL] [Abstract][Full Text] [Related]
56. Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis.
Gorantla S; Batra U; Puppala ER; Waghule T; Naidu VGM; Singhvi G
Expert Opin Drug Deliv; 2022 Apr; 19(4):395-407. PubMed ID: 35287532
[TBL] [Abstract][Full Text] [Related]
57. Development of a codrug approach for sustained drug delivery across microneedle-treated skin.
Ghosh P; Pinninti RR; Hammell DC; Paudel KS; Stinchcomb AL
J Pharm Sci; 2013 May; 102(5):1458-67. PubMed ID: 23417751
[TBL] [Abstract][Full Text] [Related]
58. Enhancement strategies for transdermal drug delivery systems: current trends and applications.
Ramadon D; McCrudden MTC; Courtenay AJ; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):758-791. PubMed ID: 33474709
[TBL] [Abstract][Full Text] [Related]
59. Fabrication of gradient porous microneedle array by modified hot embossing for transdermal drug delivery.
Li J; Zhou Y; Yang J; Ye R; Gao J; Ren L; Liu B; Liang L; Jiang L
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():576-582. PubMed ID: 30606567
[TBL] [Abstract][Full Text] [Related]
60. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
Pawar KR; Smith F; Kolli CS; Babu RJ
J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
